
11 November 2026
Cicor and CSEM Partner to Accelerate Medical Device Innovation
CSEM and Cicor Group have entered a strategic partnership to help accelerate the development of medical devices and wearable health technologies.
Where technology elevates healthcare.

Healthcare systems worldwide face major challenges, including an aging population, workforce shortages, and rising costs. At the same time, emerging trends such as mobile patient monitoring and personalized health, including Femtech, are reshaping the sector.
In response, and with a strong commitment to making preventive, personalized, and cost-effective care accessible to everyone anytime and anywhere, CSEM drives innovation in vital signs sensing technologies, advanced algorithms, and secure connected systems, enabling next-generation wearables, medical devices, and Digital Health solutions.
Through our innovations and continuously evolving expertise in Digital Health, we are uniquely positioned to support companies—from dynamic start-ups to global industry leaders—in transforming their monitoring ideas in healthcare, wellness, and sports into successful, market-ready products.
We offer a broad range of support services to accelerate your innovation journey, including IP licensing, ISO 13485/IEC 62304-compliant co-development and medical system engineering, PPG expert support, custom algorithm development, and clinical research trial support.
Building on long-standing expertise in photoplethysmography (PPG), CSEM develops high-performance optical sensing solutions. By leveraging optical PPG data, CSEM’s advanced vital signs algorithms extract a wide range of physiological parameters, including blood pressure, cardiac arrhythmia detection, oxygen saturation (SpO2), sleep metrics, heart rate, heart rate variability, breathing rate, and stress levels.
In addition, CSEM leads pioneering research in remote PPG, speckle photoplethysmography, and laser Doppler flowmetry, advancing the frontiers of non-invasive cardiovascular and perfusion monitoring.
CSEM develops advanced biopotential and bioimpedance monitoring technologies for Digital Health and medical applications. Our expertise covers a wide range of sensing modalities—including ECG, EEG, EMG, EoG, EHG, fECG, ECGi, as well as electrical impedance tomography (EIT), thoracic impedance monitoring, impedance cardiography, and impedance plethysmography.
CSEM’s expertise encompasses both traditional biopotential and bioimpedance systems, as well as innovative solutions based on its patented cooperative sensor (CS) technology. Leveraging ultra-low power, custom ASICs, this scalable CS-platform enables high-quality signal acquisition via up to 250 active dry or gel electrodes connected through a single unshielded cable of maximum 2 wires—ideal for multi-channel monitoring and imaging wearables in clinical environments, Digital Health, and research.
Current R&D activities address pregnancy monitoring and non-invasive assessment of pulmonary artery pressure (PAP) based on a combination of EIT and ECG. They also explore multifrequency EIT for continuous, non-invasive monitoring of blood glucose or other analytes.
CSEM is actively exploring emerging sensing technologies to drive tomorrow's wearable vital signs monitoring solutions. These R&D activities include compact ultrasound sensors combined with tailored reconstruction and processing algorithms, digital stethoscopes with enhanced sensing and interpretation capabilities, as well as innovative skin and core body temperature sensing approaches.
CSEM develops technologies and algorithms for analyzing and tracking motion across multiple body locations, including the wrist, foot, thorax, and head. Our algorithm portfolio covers activity classification, gait analysis, fall detection, workout profiling, sleep monitoring, and motion and gesture recognition.
Our step detector has been independently verified as best-in-class for accuracy. All solutions are designed for real-time operation with minimal power and memory requirements, making them ideal for embedded Digital Health and fitness applications.
CSEM offers a clinically validated portfolio of licensable vital signs algorithms, many of which are medical-grade. Beyond ready-to-use solutions, we develop custom vital signs algorithms by combining classic signal processing with machine learning (ML) and artificial intelligence (AI) to meet specific application needs in healthcare—for both on-edge devices and cloud-based environments.
We also explore the integration of generative AI and large language models (LLMs) into Digital Health ecosystems. We develop agentic frameworks that combine classical databases with retrieval-augmented generation (RAG) techniques to provide timely, context-aware information to clinicians and patients. These approaches aim to enhance clinical decision support, streamline workflows, and personalize patient engagement through intelligent, adaptive interfaces.
Our evolving expertise in advanced sensing technologies for wearable vital signs monitoring is complemented by a robust, evolving Internet of Medical Things (IoMT) framework and custom mobile applications, enabling secure, real-time remote patient monitoring across clinical and home environments.

We provide a comprehensive range of support services designed to accelerate your innovation journey and transform your ideas into successful, market-ready products. Our Digital Health services include:
Located at the Campus of Bern University Hospital (Inselspital) and embedded in the Bern Medtech Ecosystem, CSEM collaborates closely with clinicians and researchers to drive innovation at the intersection of microtechnology, electronics, and clinical applications. Through the Bern Medtech Collaboration Call (BMCC), clinical teams and CSEM engineers jointly identify clinical needs, co-design Digital Health solutions, and validate them under real clinical conditions.
This strong partnership with Bern University Hospital—alongside close collaborations with other renowned institutions such as Lausanne University Hospital—enables CSEM to anticipate emerging trends and develop technologies that address patient needs while delivering clinically relevant outcomes.